Next Article in Journal
Simultaneous Quantitation of Isoprenoid Pyrophosphates in Plasma and Cancer Cells Using LC-MS/MS
Next Article in Special Issue
Cross-Species Analysis of Glycosaminoglycan Binding Proteins Reveals Some Animal Models Are “More Equal” than Others
Previous Article in Journal
Construction of Highly Stable Cytotoxic Nuclear-Directed Ribonucleases
Previous Article in Special Issue
Solution Conformation of Heparin Tetrasaccharide. DFT Analysis of Structure and Spin–Spin Coupling Constants
Open AccessArticle

Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas

1
Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni, V. G. Colombo 81, 20133 Milan, Italy
2
IRCCS—Istituto Ortopedico Rizzoli, V. di Barbiano 1/10, 40136 Bologna, Italy
3
Department of Medical Genetics and Rare Orthopaedic Diseases—IRCCS, Istituto Ortopedico Rizzoli, V. di Barbiano 1/10, 40136 Bologna, Italy
4
Department of Medical Genetics and Rare Orthopaedic Diseases & CLIBI Laboratory—IRCCS, Istituto Ortopedico Rizzoli, V. di Barbiano 1/10, 40136 Bologna, Italy
*
Authors to whom correspondence should be addressed.
Molecules 2018, 23(12), 3277; https://doi.org/10.3390/molecules23123277
Received: 29 October 2018 / Revised: 23 November 2018 / Accepted: 6 December 2018 / Published: 11 December 2018
(This article belongs to the Special Issue Heparan Sulfate and Heparin: Challenges and Controversies)
Multiple osteochondromas (MO) is a hereditary disorder associated with benign cartilaginous tumors, known to be characterized by absence or highly reduced amount of heparan sulfate (HS) in the extracellular matrix of growth plate cartilage, which alters proper signaling networks leading to improper bone growth. Although recent studies demonstrated accumulation of HS in the cytoplasm of MO chondrocytes, nothing is known on the structural alterations which prevent HS from undergoing its physiologic pathway. In this work, osteochondroma (OC), peripheral chondrosarcoma, and healthy cartilaginous human samples were processed following a procedure previously set up to structurally characterize and compare HS from pathologic and physiologic conditions, and to examine the phenotypic differences that arise in the presence of either exostosin 1 or 2 (EXT1 or EXT2) mutations. Our data suggest that HS chains from OCs are prevalently below 10 kDa and slightly more sulfated than healthy ones, whereas HS chains from peripheral chondrosarcomas (PCSs) are mostly higher than 10 kDa and remarkably more sulfated than all the other samples. Although deeper investigation is still necessary, the approach here applied pointed out, for the first time, structural differences among OC, PCS, and healthy HS chains extracted from human cartilaginous excisions, and could help in understanding how the structural features of HS are modulated in the presence of pathological situations also involving different tissues. View Full-Text
Keywords: heparan sulfate; multiple osteochondromas (MO); peripheral chondrosarcoma; human cartilage; NMR; HPLC–MS; EXT heparan sulfate; multiple osteochondromas (MO); peripheral chondrosarcoma; human cartilage; NMR; HPLC–MS; EXT
Show Figures

Figure 1

MDPI and ACS Style

Veraldi, N.; Parra, A.; Urso, E.; Cosentino, C.; Locatelli, M.; Corsini, S.; Pedrini, E.; Naggi, A.; Bisio, A.; Sangiorgi, L. Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas. Molecules 2018, 23, 3277.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop